| 7th Apr 2025 10:33 am |
RNS |
Block Listing Return |
| 3rd Apr 2025 1:54 pm |
RNS |
PDMR Shareholding/Share Incentive Plan and TVR |
| 26th Mar 2025 7:00 am |
RNS |
PMx Promotional Partner Contract Enhancement |
| 6th Mar 2025 3:16 pm |
RNS |
Holding(s) in Company |
| 3rd Mar 2025 3:00 pm |
RNS |
PDMR Shareholding/Share Incentive Plan and TVR |
| 31st Jan 2025 9:13 am |
RNS |
Purchase of Shares and PDMR Shareholding |
| 30th Jan 2025 11:27 am |
RNS |
PDMR Shareholding/Share Incentive Plan |
| 28th Jan 2025 7:00 am |
RNS |
FY 2024 Trading Update - Strong Revenue Growth |
| 14th Jan 2025 7:00 am |
RNS |
Diaceutics Opens US Headquarters |
| 8th Jan 2025 7:00 am |
RNS |
New Service Launched & First Contract Signed |
| 3rd Jan 2025 3:39 pm |
RNS |
PDMR Dealings & Total Voting Rights |
| 19th Dec 2024 8:09 am |
RNS |
Holding(s) in Company |
| 17th Dec 2024 10:46 am |
RNS |
Holding(s) in Company |
| 17th Dec 2024 7:00 am |
RNS |
Diaceutics Wins New $5.1m Contract |
| 10th Dec 2024 3:14 pm |
RNS |
Holding(s) in Company |
| 5th Dec 2024 7:00 am |
RNS |
Awarded UK Research Institute Grant Funding of £1m |
| 3rd Dec 2024 2:24 pm |
RNS |
Total Voting Rights |
| 28th Nov 2024 7:00 am |
RNS |
Expansion of US Commercial Activities |
| 5th Nov 2024 7:00 am |
RNS |
Capital Markets Webinar |
| 4th Nov 2024 7:00 am |
RNS |
Holding(s) in Company |
| 30th Oct 2024 2:58 pm |
RNS |
PDMR Shareholding/Share Incentive Plan |
| 29th Oct 2024 10:27 am |
RNS |
Board Change Update |
| 25th Oct 2024 7:00 am |
RNS |
Issue of Share Options/PDMR Shareholdings |
| 24th Oct 2024 12:53 pm |
RNS |
Cancellation of Share Premium Account |
| 15th Oct 2024 7:00 am |
RNS-R |
Diaceutics Announces Key Leadership Appointment |
| 7th Oct 2024 1:19 pm |
RNS |
Holding(s) in Company |
| 7th Oct 2024 7:00 am |
RNS |
Block Listing Return |
| 2nd Oct 2024 7:00 am |
RNS |
PDMR Shareholding/Share Incentive Plan |
| 1st Oct 2024 7:00 am |
RNS |
Board Changes |
| 17th Sep 2024 7:00 am |
RNS |
H1 2024 Results - Continued Performance & Growth |
| 9th Sep 2024 7:00 am |
RNS |
Notice of Results & Presentations |
| 2nd Sep 2024 7:00 am |
RNS |
Appointment of Nominated Adviser and Broker |
| 30th Aug 2024 3:45 pm |
RNS |
PDMR Shareholding/Share Incentive Plan |
| 27th Aug 2024 7:00 am |
RNS |
Diaceutics Launches Enhanced Rare-Disease Offering |
| 19th Aug 2024 7:00 am |
RNS |
Enterprise Partnership and Launch of PMx |
| 5th Aug 2024 7:00 am |
RNS |
Presenting at Canaccord Genuity Growth Conference |
| 29th Jul 2024 6:09 pm |
RNS |
PDMR Shareholding/SIP and TVR |
| 29th Jul 2024 7:00 am |
RNS |
Issue of Share Options/PDMR Shareholdings |
| 23rd Jul 2024 7:05 am |
RNS |
Board Changes |
| 23rd Jul 2024 7:00 am |
RNS |
Revenue growth of 24% in H1 with 55% now recurring |
